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Introduction {#sec005}
============

Neuropsychiatric symptoms (NPS) normally occur during the natural course of dementia \[[@pone.0206147.ref001]\]. NPS, include symptoms such as delusions, hallucination, depression, anxiety, euphoria, agitation, aggression, apathy and disinhibition.

NPS may either be subjectively experienced by the individual with dementia or observed by their next of kin or caregivers. In people with dementia, these symptoms may contribute to a feeling of distress and discomfort, and are associated with a poorer quality of life \[[@pone.0206147.ref002]--[@pone.0206147.ref005]\]. Furthermore, more severe NPS have been found to be associated with an accelerated cognitive decline \[[@pone.0206147.ref006], [@pone.0206147.ref007]\] and increased mortality \[[@pone.0206147.ref008]\], but the results regarding increased mortality are inconsistent \[[@pone.0206147.ref009]\]. NPS tend to increase depression \[[@pone.0206147.ref010]\] and reduce quality of life \[[@pone.0206147.ref011]\] for next of kin. Moreover, higher levels of NPS are associated with a greater burden on informal caregivers \[[@pone.0206147.ref010], [@pone.0206147.ref012]\] and an increase in the cost of care \[[@pone.0206147.ref013]\]. NPS are a cause of institutionalization for people with dementia \[[@pone.0206147.ref009], [@pone.0206147.ref014]\] and present a significant challenge in dementia care \[[@pone.0206147.ref015]\].

In Norway, as in other Western countries, a large proportion of nursing home residents suffer from dementia \[[@pone.0206147.ref016]--[@pone.0206147.ref020]\], and NPS are highly prevalent \[[@pone.0206147.ref021]\]. NPS show a heterogeneous course \[[@pone.0206147.ref022]\]. A review from 2013 based on seven follow-up studies of nursing home residents with dementia found that the persistence of individual NPS varied substantially, but most studies reported residents with at least one NPS \[[@pone.0206147.ref021]\]. One limitation of this review was that it included few studies and those studies featured a great deal of methodological diversity. For example, five different assessment tools were used to assess NPS, three of seven studies had fewer than 100 participants, and only two studies followed residents consecutively after admission to the nursing home. The first months after admission to a nursing home may be stressful for patients with dementia and accompanied with NPS. Thus, the length of nursing home stay prior to study inclusion may influence the prevalence and course of NPS described in the study \[[@pone.0206147.ref022]\]. Additionally, six of the seven studies had a follow-up of less than two years, and the time between assessments varied from 2 months to one year. Time between assessments and duration of follow-up may be important in determining the degree of persistence and associations reported \[[@pone.0206147.ref023]\]. Recently, a study of nursing home residents with dementia with four assessments over 53 months found agitation, irritability, disinhibition and apathy most prevalent and persistent during the study period, while an increase in dementia severity was associated with an increase in agitation, psychosis and apathy, but not affective symptoms \[[@pone.0206147.ref024]\]. There is a great need for new studies to further improve the knowledge concerning persistence and natural course of a broad spectrum of NPS in nursing home residents, and to address the methodological limitations reported \[[@pone.0206147.ref021]--[@pone.0206147.ref023]\]. In other words, we need large longitudinal studies that include residents consecutively at admission to a nursing home and where regular assessments over a longer study period are made. This information is vital for planning interventions and treatment of NPS in nursing home residents with dementia \[[@pone.0206147.ref021], [@pone.0206147.ref023]\].

The relationship between NPS, the dementia itself and individual and environmental factors is not fully understood \[[@pone.0206147.ref015], [@pone.0206147.ref025]\]. NPS might be an expression of the underlying brain disease \[[@pone.0206147.ref026]\], but increased vulnerability to stress and stimuli in the environment because of the disease may contribute to increasing the risk of NPS \[[@pone.0206147.ref025], [@pone.0206147.ref027]\]\[[@pone.0206147.ref028]\]. In nursing home residents, environmental factors that contribute to stress and NPS may be characteristics of the psychosocial/physical environment, including type and degree of assistance received \[[@pone.0206147.ref015], [@pone.0206147.ref025], [@pone.0206147.ref029]--[@pone.0206147.ref031]\]. Apart from dementia, individual risks may include age, gender, marital status, physical functioning, physical health and use of medication \[[@pone.0206147.ref015], [@pone.0206147.ref023], [@pone.0206147.ref025]\].

The aims of this study were to describe the prevalence, incidence and persistence of clinically significant NPS in nursing home residents with dementia at admission and with biannual assessments over a 30-month follow-up period, and to study the association between the severity of dementia and the development of neuropsychiatric sub-syndromes using the Neuropsychiatric Inventory (NPI).

Methods {#sec006}
=======

Design {#sec007}
------

This was an observational longitudinal study composed of participants from a convenience sample of 47 nursing homes in four Norwegian counties, representing small and large nursing homes that were located in both urban and rural areas \[[@pone.0206147.ref032]\]. The baseline data were collected within one month after admission to the nursing home between March 2012 and November 2014. The follow-up data were collected every six months or until the death of the participant. Follow-up assessments are still ongoing, but the present study includes information from baseline (T~1~) until the 30-month follow-up (T~6~), which all remaining participants had passed in May 2017.

Setting and participants {#sec008}
------------------------

With a population of about 5.3 million and about 700,000 (14%) people aged 65 years or older \[[@pone.0206147.ref033]\], Norway has about 40,000 nursing home places (beds) \[[@pone.0206147.ref034]\]. The country's health care services are public, and jurisdiction lies within the local municipalities. Services provided include social services (such as housing and home services), in-home nursing and institutional care (mainly in nursing homes), and both long- and short-term care and rehabilitation.

In total, 696 residents with an expected stay longer than four weeks were recruited at admission to the nursing home. All residents 65 years and older independent of whether they had established dementia or not and residents younger than 65 years with established dementia were recruited at admission. The only exclusion criterion was a life expectancy of less than six weeks \[[@pone.0206147.ref032]\]. In the present article only those with dementia at admission were included. Two physicians (SB & GS) independently diagnosed dementia at baseline according to the ICD-10 criteria using all the available information at first assessment. In situations where the physicians disagreed, a third physician was consulted \[[@pone.0206147.ref032]\]. All physicians had extensive experience in research and clinical old age psychiatry. At admission to the nursing home, 583 residents had dementia and 113 residents did not have dementia \[[@pone.0206147.ref032]\]. Additional information regarding the setting and participants has been published elsewhere \[[@pone.0206147.ref032]\].

Measures {#sec009}
--------

Neuropsychiatric symptoms (NPS) were measured at each assessment using the Neuropsychiatric Inventory Nursing Home version (NPI-NH) \[[@pone.0206147.ref035]\]. The NPI is translated to Norwegian and validated \[[@pone.0206147.ref036]\]. The 12-item inventory were used, and it covers the following symptoms: delusion, hallucination, euphoria, agitation/aggression, disinhibition, irritability/lability, depression/dysphoria, anxiety, apathy/indifference, aberrant motor behavior, night-time behavior disturbances, and appetite and eating disorders (yes/no). Each symptom provides a score from zero to 12, i.e. severity (score 1--3) was multiplied by frequency (score 1--4). A score of four and higher was defined as a clinically significant symptom \[[@pone.0206147.ref037]\]. Three sub-syndrome scores were established, based on a previous principal component analysis, i.e. psychosis (including the sum-score of delusions and hallucination), agitation (including the sum-score of agitation/aggression, disinhibition and irritability), and affective (including the sum-score of depression and anxiety) \[[@pone.0206147.ref038]\].

Severity of dementia was measured at each assessment using the Norwegian version of the Clinical Dementia Rating (CDR) scale with five response categories (0, 0.5, 1, 2, 3) \[[@pone.0206147.ref039], [@pone.0206147.ref040]\]. The scale covers six domains (memory, orientation, judgment and problem solving, community affairs, home and hobbies and personal care), and the categorical score is calculated using an algorithm that gives priority to memory \[[@pone.0206147.ref039]\]. The categorical scores indicate dementia, ranging from 0 (no dementia) to 3 (severe dementia). A sum-score of the six domains (CDR Sum of Boxes, CDR-SoB), ranging from zero to 18 offers important advantages when analyzing data. A higher score is indicating more severe dementia. The correlation between the categorical CDR and the CDR-SoB is high \[[@pone.0206147.ref041], [@pone.0206147.ref042]\]. The Spearman correlation between the categorical CDR and the CDR-SoB score in the present study was 0.87 at baseline.

Use of psychotropic medications were collected from the medical record of each resident \[[@pone.0206147.ref043]\]. The medication were grouped according to the ATC code into the following categories: antipsychotics (N05A except lithium), antidepressants (N06A), anxiolytics (N05B), hypnotics/sedatives (N05C), and anti-dementia medication (N06D) (yes/no) \[[@pone.0206147.ref044]\].

Personal Activities of Daily Living (P-ADL) was assessed with the Physical Self-Maintenance Scale (PSMS) \[[@pone.0206147.ref045]\]. The scale includes six items with a total score ranging from 6 to 30 and higher scores indicate a lower level of functioning.

Physical health was assessed using a one-item global rating scale, i.e. the General Medical Health Rating (GMHR) scale \[[@pone.0206147.ref046]\]. The scale has four responses categories: very good, good, fairly good and poor. The rating was based on all available information of physical health and prescription drug use. The scale is previous used in large studies including older people with and without dementia \[[@pone.0206147.ref047]\] also in Norway \[[@pone.0206147.ref048]\].

Demographic information such as age, gender, and marital status was collected from the medical records. The type of unit was categorized as: regular unit (RU), and special care unit for people with dementia (SCU).

Procedure {#sec010}
---------

The data collection was undertaken by healthcare workers, mainly registered nurses (74%) in the nursing homes, under the supervision of 10 research nurses. The research nurses completed a five-day training program, while data collectors took a two-day training program prior to the data collection. The data came from a standardized interview with the residents, the next of kin, the residents' caregivers in the nursing home, and from medical records.

The residents' capacity to consent to participate in the study was assessed by the nursing home staff, including the nursing home physician. A written consent was obtained from all residents who had the capacity to give consent. If a resident lacked the ability to give consent, the resident's next of kin consented on behalf of the resident. These procedures have been recommended and approved by the Norwegian Regional Ethics Committee South East (2011/1738a) \[[@pone.0206147.ref032]\].

Data analysis {#sec011}
-------------

Sample characteristics at baseline were presented as means and standard deviations (SD) or frequencies and percentages. Prevalence, incidence and persistence in clinically significant NPS were calculated. Prevalence was defined as the proportion of nursing home residents with a specific clinically significant symptom present at each assessment; incidence was defined as the proportion of NH residents with a specific clinically significant symptom occurring for the first time at one assessment of the NH residents without the same clinically significant symptom reported from previous assessments; and persistence at two consecutive time points was defined as the proportion of NH residents with a specific clinically significant symptom at one assessment given the number of residents with the same clinically significant symptom at the previous assessments.

Time trends in sub-syndromes and NPI total scores were assessed by a linear mixed model with random effects for patients and units, and fixed effects for time up to second order. Next, CDR-SoB was included as a fixed effect along with the interaction between CDR-SoB and time. A significant interaction would imply a varying association between sub-syndromes and CDR-SoB throughout the follow-up period. Finally, models were adjusted for clinical and demographic characteristics. To easy the interpretation, the significant interactions were illustrated graphically for four arbitrarily chosen CDR-SoB values.

All analyses were performed in SPSS version 25 and SAS v9.4. Results with p-values below 0.05 were considered statistically significant. All tests were two-sided.

Results {#sec012}
=======

Sample characteristics {#sec013}
----------------------

At baseline, the mean (SD) age of the participants was 84.0 (7.5) years and 375 (64.3%) were women ([Table 1](#pone.0206147.t001){ref-type="table"}). The mean (SD) baseline CDR-SoB was 11.2 (3.6).

10.1371/journal.pone.0206147.t001

###### Sample characteristics at baseline (N = 583).

![](pone.0206147.t001){#pone.0206147.t001g}

  Characteristics                                        N
  --------------------------- ----------- -------------- -----
  *Socio-demographics*                                   
  Age                         Mean (SD)   84.0 (7.5)     580
  Females                     N (%)       375 (64.3)     583
  Married                     N (%)       186 (32.3)     576
  *Health condition*                                     
  CDR-SoB                     Mean (SD)   11.24 (3.59)   576
  GMHR                                                   
     Fairly poor/Poor         N (%)       280 (50.3)     557
     Good/Fairly good         N (%        277 (49.7      
  PSMS score                  Mean (SD)   15.3 (4.5)     582
  Use of Psychotropic drugs                              
     Antipsychotics           N (%)       72 (12.3)      583
     Antidepressants          N (%)       167 (28.6)     583
     Anxiolytics              N (%)       89 (15.3)      583
     Sedatives                N (%)       128 (22.0)     583
     Anti-dementia drugs      N (%)       163 (28.0)     583
  *NH characteristics*                                   
     RU                       N (%)       367 (63.0)     583
     SCU                      N (%)       216 (37.0)     
  *Type of dementia*                                     
     AD                       N (%)       414 (71.0)     583
     VAD                      N (%)       46 (7.9)       
     AD/VAD                   N (%)       11 (1.9)       
     FTD                      N (%)       47 (8.1)       
     LBD/PD                   N (%)       22 (3.8)       
     Unspecified              N (%)       43 (7.4)       

CDR-SoB: The sum-score of the domains in the Clinical Dementia Rating scale, GMHR: General Medical Health rating, PSMS: Physical Self-Maintenance Scale N H: Nursing home, RU: regular unit, SCU: Special care unit, AD: Alzheimer's disease, VAD: Vascular dementia, AD/VAD: Alzheimer's disease mixed type, FTD: Frontotemporal dementia, LBD/PD: Lewy body dementia/ Parkinson's disease

Of the 583 residents at baseline, 210 (36%) were assessed after 30 months ([Table 2](#pone.0206147.t002){ref-type="table"}). Attrition was mainly due to death (n = 305). Mean (SD) time of follow-up was 655.6 (305.6) days.

10.1371/journal.pone.0206147.t002

###### Number of participants at each assessment in the study sample.

![](pone.0206147.t002){#pone.0206147.t002g}

                                   T~1~ (Baseline)   T~2~ (6 months)   T~3~ (12 months)   T~4~ (18 months)   T~5~ (24 months)   T~6~ (30 months)
  -------------------------------- ----------------- ----------------- ------------------ ------------------ ------------------ ------------------
  Number included                  583               469               387                322                269                221
  Number assessed                  583               437               374                307                261                210
  Number left                                        114               82                 65                 53                 48
  Due to death                                       84                67                 61                 51                 42
  Other reasons                                      30                15                 4                  2                  6
     NH withdrawn                                    1                                    2                                     
     Patient withdrawn                               4                 2                                                        
     Moved to another unit of NH                     13                5                  2                  1                  5
     Moved home                                      12                8                                     1                  
     Unknown                                                                                                                    1

NH: Nursing home

Prevalence and incidence of clinically significant neuropsychiatric symptoms over time {#sec014}
--------------------------------------------------------------------------------------

The prevalence of clinically significant NPS at baseline and at follow-up is presented in [Table 3](#pone.0206147.t003){ref-type="table"}. The three most prevalent clinically significant NPS at baseline were depression (21.8%), anxiety (21.9%) and irritability (19.2%). The prevalence during follow-up varied between 21.3% to 23.2%, 20.8% to 26.5, and 24.8% to 37.1% for depression, anxiety and irritability, respectively. The least frequent clinically significant NPS at baseline were euphoria (3.7%) and hallucination (5.8%) and the prevalence of these symptoms was also low during the follow-up, between 4.2% to 6.4% and 5.0% to 10.4%, respectively. At baseline, 61.9% had at least one clinically significant NPS. The cumulative incidence of any clinically significant NPS thereafter was 28.7%. The cumulative incidence of clinically significant individual NPS was higher than 20% for eight of twelve symptoms (delusion, agitation, depression, anxiety, apathy, disinhibition, irritability and appetite and eating disorders), and lower than 10% for only one symptom, euphoria.

10.1371/journal.pone.0206147.t003

###### Prevalence, incidence and persistence of significant neuropsychiatric symptoms (NPS) at each assessment (%).

![](pone.0206147.t003){#pone.0206147.t003g}

  ---------------------------------------------------------------------------- -------------------------------- ------------------ ------------------- ------------------- ------------------- -------------------
                                                                               T~1~ (Baseline)\                 T~2~ (6 months)\   T~3~ (12 months)\   T~4~ (18 months)\   T~5~ (24 months)\   T~6~ (30 months)\
                                                                               N = 583                          N = 437            N = 374             N = 307             N = 261             N = 210

  Prevalence                                                                                                                                                                                   

  Delusions                                                                    16.0                             18.5               19.9                22.3                22.5                21.7

  Hallucinations                                                               5.8                              8.2                5.0                 8.7                 10.4                7.6

  Agitation                                                                    16.2                             16.0               21.6                22.3                27.1                25.1

  Depression                                                                   21.8                             22.0               21.6                23.2                21.3                21.6

  Anxiety                                                                      21.9                             20.8               21.2                24.9                26.5                24.1

  Euphoria                                                                     3.7                              4.2                4.6                 5.3                 6.4                 5.9

  Apathy                                                                       16.6                             12.2               13.5                17.5                23.4                21.9

  Disinhibition                                                                16.1                             16.6               18.5                19.0                29.2                26.6

  Irritability                                                                 19.2                             24.8               27.3                34.5                36.8                37.1

  Aberrant Motor Behavior                                                      12.0                             11.4               12.1                14.4                15.1                14.0

  Nighttime Behavior                                                           17.0                             15.0               11.8                12.0                13.9                10.3

  Appetite and eating disorder                                                 10.1                             9.5                7.4                 14.1                12.3                12.3

  Any symptom                                                                  61.9                             55.5               59.5                67.0                69.6                65.4

  Cumulative incidence (%) and incidence between two consecutive time points                                                                                                                   

                                                                               Cumulative incidence (N = 583)   T~1~-T~2~          T~2~-T~3~           T~3~-T~4~           T~4~-T~5~           T~5~-T~6~

  Delusions                                                                    24.5                             13.2               9.5                 11.5                12.6                11.4

  Hallucinations                                                               10.8                             5.8                2.0                 4.5                 3.7                 2.4

  Agitation                                                                    23.7                             9.7                12.6                12.4                12.6                10.5

  Depression                                                                   22.7                             14.4               12.3                14.0                9.8                 9.7

  Anxiety                                                                      24.7                             12.4               12.3                13.9                11.9                13.1

  Euphoria                                                                     9.1                              3.2                2.8                 4.0                 4.9                 3.4

  Apathy                                                                       25.5                             7.8                10.4                12.1                15.7                9.7

  Disinhibition                                                                24.7                             9.0                10.4                11.4                18.0                13.5

  Irritability                                                                 31.6                             15.0               13.6                22.0                15.0                21.0

  Aberrant Motor Behavior                                                      17.4                             6.7                6.1                 9.2                 10.0                7.5

  Nighttime Behavior                                                           23.6                             8.9                5.8                 12.4                36.5                24.1

  Appetite and eating disorder                                                 28.7                             33.7               33.7                47.9                8.3                 7.6

  Any symptom                                                                  15.8                             7.9                4.5                 6.4                 8.1                 4.3

  Persistence of symptoms at two consecutive time points (%)                                                                                                                                   

                                                                                                                T~1~-T~2~          T~2~-T~3~           T~3~-T~4~           T~4~-T~5~           T~5~-T~6~

  Delusions                                                                                                     46.4               66.7                62.1                52.7                54.3

  Hallucinations                                                                                                48.0               48.0                66.7                75.0                55.6

  Agitation                                                                                                     52.3               72.5                57.6                70.7                63.6

  Depression                                                                                                    52.3               59.4                57.4                58.8                58.1

  Anxiety                                                                                                       52.7               58.8                61.7                67.7                61.7

  Euphoria                                                                                                      27.8               31.3                33.3                35.7                54.5

  Apathy                                                                                                        35.9               42.9                52.5                51.2                56.5

  Disinhibition                                                                                                 53.7               58.2                56.9                63.3                63.0

  Irritability                                                                                                  64.1               71.6                67.5                73.6                71.6

  Aberrant Motor Behavior                                                                                       43.4               57.1                56.3                38.9                50.0

  Nighttime Behavior                                                                                            51.4               50.0                45.9                64.0                44.8

  Appetite and eating disorder                                                                                  17.1               40.0                31.8                39.4                45.0

  Any symptom                                                                                                   70.1               82.1                80.2                86.3                84.1
  ---------------------------------------------------------------------------- -------------------------------- ------------------ ------------------- ------------------- ------------------- -------------------

Persistence of clinically significant NPS over time {#sec015}
---------------------------------------------------

The persistence of any clinically significant NPS was 70.1% between the two first assessments (baseline and 6-month follow-up), while the persistence of any clinically significant NPS for the remainder of the assessments varied between 80.2%-86.3%. The persistence of individual clinically significant NPS from baseline to the first follow-up was higher than 50% for agitation (52.3%), depression (52.3%), anxiety (52.7%), disinhibition (53.7%), irritability (64.1%) and nighttime behavior (51.4%). For these symptoms, the persistence during the rest of the study period was also higher than 50%, except for nighttime behavior. The persistence of irritability was higher than 70% three times during the study period (T~2~-T~3~, T~4~-T~5~ and T~5~-T~6~). The two symptoms with lowest persistence from baseline to the first follow-up were appetite and eating disorders (17.1%) and euphoria (27.8%). In the follow-up period, the persistence of these clinically significant NPS exceeded 30% from T~2~-T~3~ and remained at this level or higher throughout the study period. The persistence of apathy increased from 35.9% between the two first assessments (T~1~-T~2~) to 56.5% between the last two assessments (T~5~-T~6~).

Factors associated with NPI sub-syndromes {#sec016}
-----------------------------------------

The mean NPI agitation sub-syndrome score increased significantly during the study period ([Table 4](#pone.0206147.t004){ref-type="table"} and [Fig 1A](#pone.0206147.g001){ref-type="fig"}). In an unadjusted analysis, higher CDR-SoB values were significantly associated with a higher NPI agitation sub-syndrome score measured simultaneously, with a stronger association towards the end of study period ([Table 5](#pone.0206147.t005){ref-type="table"} and [Fig 2A](#pone.0206147.g002){ref-type="fig"}). The increase in the NPI agitation sub-syndrome score throughout the study period was only significant for values of CDR-SoB of 8 or more.

![The mean (95% CI) NPI sub-syndrome scores over time for agitation (1A), affective (1B) and psychosis (1C).](pone.0206147.g001){#pone.0206147.g001}

![**The unadjusted associations of the NPI agitation sub-syndrome (2A), NPI affective sub-syndrome (2B) and NPI psychosis sub-syndrome (2C) by CDR-SoB over time**.](pone.0206147.g002){#pone.0206147.g002}

10.1371/journal.pone.0206147.t004

###### Sub-syndrome and total sum-scores of neuropsychiatric inventory at each time point.

![](pone.0206147.t004){#pone.0206147.t004g}

                               T~1~          T~2~          T~3~          T~4~          T~5~          T~6~
  ---------------------------- ------------- ------------- ------------- ------------- ------------- -------------
  NPI Agitation sub-syndrome                                                                         
  N                            561           423           361           298           249           198
  Mean (SD)                    4.5 (7.3)     5.0 (7.8)     5.8 (8.3)     6.0 (8.0)     7.9 (9.6)     7.2 (9.2)
  NPI Psychosis sub-syndrome                                                                         
  N                            560           421           355           291           248           196
  Mean (SD)                    1.9 (4.2)     2.4 (4.6)     2.2 (3.9)     2.8 (4.7)     2.8 (4.7)     2.5 (4.0)
  NPI Affective sub-syndrome                                                                         
  N                            572           429           364           296           245           198
  Mean (SD)                    3.9 (5.9)     3.8 (5.8)     3.7 (5.4)     4.3 (5.8)     4.0 (5.4)     3.7 (5.4)
  NPI total sum-score                                                                                
  N                            535           402           335           270           233           186
  Mean (SD)                    14.9 (17.3)   15.3 (18.9)   15.7 (17.9)   17.5 (18.4)   19.7 (21.0)   18.7 (20.6)

NPI: Neuropsychiatric Inventory

After adjustment for demographic and clinical characteristics, the association between CDR-SoB and the NPI agitation sub-syndrome score remained significant throughout the follow-up. The NPI agitation sub-syndrome score significantly increased through the study period for CDR-SoB values of 12 or higher. In the same adjusted analysis, higher PSMS, use of antipsychotics and sedatives, lower age and staying in SCU at baseline were associated with higher NPI agitation sub-syndrome scores.

The mean NPI affective sub-syndrome score was stable during the study period ([Table 4](#pone.0206147.t004){ref-type="table"} and [Fig 1B](#pone.0206147.g001){ref-type="fig"}). In an unadjusted analysis, a higher CDR-SoB was associated with a higher NPI affective sub-syndrome score measured simultaneously, but the association became weaker with time ([Table 5](#pone.0206147.t005){ref-type="table"} and [Fig 2B](#pone.0206147.g002){ref-type="fig"}).

10.1371/journal.pone.0206147.t005

###### Sub-syndromes of neuropsychiatric inventory by time and severity of dementia.

![](pone.0206147.t005){#pone.0206147.t005g}

  Variables                                   NPI Agitation         NPI Affective   NPI Psychosis                                                                                                                                                         
  ------------------------------------------- --------------------- --------------- --------------------- ------------- --------------------- ------------- -------------------- ------------- ---------------------- ------------- --------------------- -------------
  Main variables                                                                                                                                                                                                                                          
  Time                                        -0.04 (0.06)          0.542           -0.06 (0.06)          0.360         0.04 (0.04)           0.339         0.01 (0.04)          0.772         0.03 (0.03)            0.407         0.01 (0.03)           0.670
  Time x Time                                 -0.001 (0.002)        0.386           -0.001 (0.002)        0.675         -0.0004 (0.001)       0.757         0.0006 (0.001)       0.597         -0.002 (0.0009)        0.086         -0.001 (0.001)        0.185
  CDR-SoB                                     0.47 (0.07)           **\<0.001**     0.36 (0.07)           **\<0.001**   0.34 (0.05)           **\<0.001**   0.23 (0.05)          **\<0.001**   0.22 (0.04)            **\<0.001**   0.21 (0.04)           **\<0.001**
  Time x CDR- SoB                             0.009 (0.004)         **0.037**       0.007 (0.004)         0.084         -0.004 (0.003)        0.168         -0.006 (0.003)       **0.049**     0.001 (0.002)          0.677         0.001 (0.002)         0.565
  Variables assessed at the same time point                                                                                                                                                                                                               
  GMHR                                                                                                                                                                                                                                                    
     Good/Fairly good                         0                     \-              0                     \-            0                     \-            0                    \-            0                      \-            0                     \-
     Poor/Fairly bad                          0.96 (0.26;1.66)      **0.007**       0.16 (-0.55;0.87)     0.662         0.98 (0.47;1.48)      **\<0.001**   0.61 (0.09;1.12)     **0.020**     0.35 (-0.03;0.74)      0.072         0.20 (-0.20;0.59)     0.330
  Marital status                                                                                                                                                                                                                                          
     Not married                              -1.77 (-2.86;-0.69)   **0.001**       -0.77 (-1.83;0.29)    0.155         -0.57 (-1.36;0.22)    0.160         -0.45 (-1.24;0.34)   0.266         -0.88 (-1.47; -0.30)   **0.003**     -0.74 (-1.32;-0.15)   **0.014**
     Married                                  0                     \-              0                     \-            0                     \-            0                    \-            0                      \-            0                     \-
  PSMS score                                  0.35 (0.27;0.44)      **\<0.001**     0.14 (0.04;0.24)      **0.007**     0.23 (0.17; 0.30)     **\<0.001**   0.13 (0.06;0.21)     **0.001**     0.09 (0.04;0.13)       **\<0.001**   -0.03 (-0.08;0.03)    0.361
  Use of PTD                                                                                                                                                                                                                                              
     Antipsychotics                           2.53 (1.51;3.56)      **\<0.001**     1.81 (0.82;2.81)      **\<0.001**   1.55 (0.81;2.30)      **\<0.001**   1.04 (0.31;1.77)     **0.005**     1.90 (1.33;2.46)       **\<0.001**   1.61 (1.05;2.17)      **\<0.001**
     Antidepressants                          0.45 (-0.38;1.28)     0.288           -0.03 (-0.84;0.77)    0.941         1.92 (1.33;2.51)      **\<0.001**   1.57 (0.99; 2.16)    **\<0.001**   0.13 (-0.32;0.58)      0.580         -0.11 (-0.56;0.34)    0.625
     Anxiolytics                              1.02 (0.09;1.95)      **0.032**       0.67 (-0.23; 1.58)    0.143         0.61 (-0.06;1.28)     0.077         0.17 (-0.49;0.82)    0.618         0.69 (0.18;1.20)       **0.008**     0.47 (-0.03;0.98)     0.066
     Sedatives                                1.54 (0.69;2.39)      **\<0.001**     1.53 (0.70;2.36)      **\<0.001**   1.24 (0.63; 1.88)     **\<0.001**   0.96 (0.36;1.56)     **0.002**     0.70 (0.23;1.16)       **0.003**     0.57 (0.11;1.03)      **0.016**
  Variables assessed at baseline                                                                                                                                                                                                                          
  Age                                         -0.19 (-0.26;-0.12)   **\<0.001**     -0.14 (-0.21;-0.06)   **\<0.001**   -0.07 (-0.12;-0.01)   **0.016**-    -0.03 (-0.09;0.02)   0.232         -0.03 (-0.08;0.005)    0.089         -0.007 (-0.05;0.03)   0.718
  Gender                                                                                                                                                                                                                                                  
     Females                                  -1.05 (-2.18;0.09     0.072           -0.34 (-1.41;0.73)    0.534         1.22 (0.40;2.05)      **0.004**     1.45 (0.65;2.26)     **\<0.001**   -0.12 (-0.72;0.49)     0.707         0.17 (-0.42;0.76)     0.576
     Males                                    0                     **-**           0                     **-**         0                     **-**         0                    \-            0                      \-            0                     \-
  Type NH unit                                                                                                                                                                                                                                            
     SCU                                      3.28 (2.12;4.45)      **\<0.001**     2.17 (1.14;3.20)      **\<0.001**   1.12 (0.27;1.96)      **0.010**     0.81 (-0.02;1.63)    0.055         1.29 (0.69;1.88)       **\<0.001**   0.79 (0.22;1.35)      **0.007**
     RU                                       0                     **-**           0                     **-**         0                     **-**         0                    \-            0                      \-            0                     \-

CDR-SoB: Clinical Dementia Rating---Sum of Boxes, GMHR: General Medical Health rating, PSMS: Physical Self-Maintenance Scale. PTD: Psychotropic medications, NH: Nursing home, RU: Regular unit, SCU: Special care unit

In the adjusted analysis, a higher CDR-SoB was associated with a higher NPI affective sub-syndrome score in the beginning of the study period, but the strength of the association diminished at the end of the study period. In the same adjusted analysis, poor GMHR, higher PSMS, female gender, and use of antipsychotics, antidepressants and sedatives were associated with a higher NPI affective sub-syndrome score.

The mean NPI psychosis sub-syndrome score was quite stable during the study period ([Table 4](#pone.0206147.t004){ref-type="table"} and [Fig 1C](#pone.0206147.g001){ref-type="fig"}). In both unadjusted and adjusted analyses, a higher CDR-SoB score was associated with a higher score on the NPI psychosis sub-syndrome score measured simultaneously, and the association remained stable for all values of CDR-SoB ([Table 5](#pone.0206147.t005){ref-type="table"} and [Fig 2C](#pone.0206147.g002){ref-type="fig"}). In the adjusted model, being married, use of antipsychotics and sedatives, and being a resident in SCU at baseline were associated with a higher NPI psychosis sub-syndrome score.

Discussion {#sec017}
==========

The prevalence and persistence of at least one clinically significant NPS was high from admission to NH and throughout the 30-month study period, i.e. ranging from 56% to 70% and 70% to 86%, respectively. The three most prevalent NPS at baseline were irritability, depression, and anxiety, and the prevalence of these symptoms remained high. The persistence of irritability, depression, anxiety, agitation and disinhibition exceeded 50% between all assessments. The mean NPI agitation sub-syndrome score increased during the study period, while the mean NPI affective and psychosis sub-syndrome scores remained unchanged. More severe dementia was associated with a higher NPI agitation and psychosis sub-syndrome score, an association that remained unchanged over time. More severe dementia was associated with a higher score on the NPI affective sub-syndrome in the beginning of the study period, but the strength of the association fell over time, and at the end of the study period the association had nearly disappeared. Use of antipsychotics and sedatives were associated with higher scores of all NPI sub-syndromes measured at the same time point.

The high prevalence and persistence between two consecutive assessments of at least one clinically significant NPS found in the present study is in line with previous studies \[[@pone.0206147.ref024]\]. The cumulative incidence of any clinical significant NPS after baseline was 29%. The high baseline prevalence (61.9%) along with the cumulative incidence indicate that most residents with dementia had at least one NPS at one time point during the study period \[[@pone.0206147.ref001]\].

Agitation is a clinical concept that includes a number of different symptoms \[[@pone.0206147.ref024]\]. A review of studies using NPI in persons with Alzheimer's disease revealed that the symptoms included in this sub-syndrome may vary \[[@pone.0206147.ref049]\]. Even so, the review did not include nursing home studies. In Norwegian studies of nursing home residents with dementia, the items agitation/aggression, disinhibition and irritability have been used to comprise the NPI agitation sub-syndrome, which is comparable to the symptoms used in international nursing home studies of residents with dementia \[[@pone.0206147.ref038], [@pone.0206147.ref050]--[@pone.0206147.ref052]\]. In the present study, the high baseline prevalence of the clinically significant symptom of irritability increased over time, as did the clinically significant symptoms of agitation and disinhibition. Furthermore, the persistence was high for these clinically significant symptoms at all consecutively compared time points. Our findings on prevalence and persistence were similar to results from studies that did not consecutively include nursing home residents with dementia at admission \[[@pone.0206147.ref022], [@pone.0206147.ref024]\]. The high and over time increasing prevalence as well as the high persistence of these symptoms in the present study and the previous \[[@pone.0206147.ref022], [@pone.0206147.ref024]\] underscore the strain the nursing home residents may experience, but also the care challenges the nursing staff may experience related to these symptoms. The mean score for the NPI agitation sub-syndrome increased during the entire study period of 30 months. There was an association between greater severity of dementia and a higher agitation score. The agitation score increased through the study period for those with more severe dementia (CDR-SoB ≥ 12). This finding is comparable with a previous small longitudinal study of nursing home residents with dementia over 18 months with biannual assessments \[[@pone.0206147.ref053]\]. Agitation in residents with the most severe dementia increased to last follow-up, but the level of agitation did not change over time in those with moderate dementia \[[@pone.0206147.ref053]\]. Agitation in residents with dementia has been linked to unmet needs \[[@pone.0206147.ref054]\]. The unmet needs model postulates that the dementia process decreases residents' ability to satisfy or accommodate their needs \[[@pone.0206147.ref054]\]. Those with severe dementia have severely limited abilities to express their needs due to impaired communication and cognition. For care staff, identification of these patients' needs is harder as the severity of the patient's dementia increases, and even when recognized, the caregivers may not fulfill them \[[@pone.0206147.ref055]\]. In addition, greater agitation and more severe dementia are both linked to the underlying brain disease \[[@pone.0206147.ref026]\]. The increase in agitation over time may partly be a result of the advancing brain disease in residents with the most severe dementia. Knowledge about the course of the NPI agitation sub-syndrome over time in general, the relation between severity of dementia and the severity of agitation and the unmet needs model are important for health care planners and nursing staff so they can better organize and adapt care for residents. In addition, it is important for caregivers to keep in mind that poorer P-ADL function as well as younger age might be factors important in generating higher NPI agitation sub-syndrome scores. Several studies have found an association between younger age and more pronounced P-ADL impairment and higher agitation \[[@pone.0206147.ref056]\]. We found that the severity of agitation was higher among residents in SCU. One explanation, which is in keeping with our clinical experience, may be that severe NPS is a reason for admission to an SCU. However, due to the nature of this study, we cannot rule out the possibility that being in an SCU is an additional, exacerbating factor for the severity of agitation.

The NPI affective sub-syndrome in the present study included depression and anxiety symptoms. Clinically significant depression and anxiety were among the most frequent NPS registered at baseline in our study, with a prevalence level that was comparable to other studies \[[@pone.0206147.ref024]\]. The prevalence of clinically significant depression and anxiety and the mean score of the NPI affective sub-syndrome remained unchanged during the 30-month study period. The persistence of clinically significant symptoms of depression and anxiety at two consecutive time points was higher than 50%, and the cumulative incidence of these symptoms was considerable. This indicates an intermittent course of depression and anxiety symptoms, as has been found by others exploring NPS in nursing home residents with dementia \[[@pone.0206147.ref023], [@pone.0206147.ref025]\]. This finding merit further investigations. Unlike most nursing home studies, the present study followed residents with dementia from admission, which gave us the opportunity to explore the course of affective symptoms after admission. We found that residents with more severe dementia had a higher NPI affective sub-syndrome score in the first 18 months after admission to the nursing home compared to residents with less severe dementia, but also that the differences in the NPI affective sub-syndrome scores according to the severity of the dementia diminished over the study period. This may be explained by the fact that individuals with severe dementia are more vulnerable for stress and change in of environment \[[@pone.0206147.ref027], [@pone.0206147.ref028], [@pone.0206147.ref057], [@pone.0206147.ref058]\]. Even so, after some time, affective symptoms may be attenuated as residents learn to adjust to the situation \[[@pone.0206147.ref059]\]. Even if affective symptoms in dementia may be understood as ineffective attempts of the resident to cope with stress factors, other explanations may be found. It might be that residents with more severe dementia over time have more difficulties expressing affective symptoms than residents with less severe dementia due to more severe communication difficulties. Thus, it could be harder for caregivers to understand the patient's expression of anxiety and depression, which could be mistaken for apathy. There is substantial evidence suggesting that affective symptoms share complex pathophysiological routes with dementia \[[@pone.0206147.ref025]\]. NPS generally tend to worsen when the severity of dementia increases \[[@pone.0206147.ref021], [@pone.0206147.ref056], [@pone.0206147.ref060]\]. Even so, not all studies have found an association between severity of dementia and severity of affective symptoms in nursing home residents, but only a minority of these studies have included residents beginning with admission to the nursing home \[[@pone.0206147.ref056]\] \[[@pone.0206147.ref021], [@pone.0206147.ref022], [@pone.0206147.ref061]\]. However, other studies have found an association between female gender, poor health, personal functioning and affective symptoms \[[@pone.0206147.ref056]\], as we found in our study, but the findings on the association between gender and affective symptoms are conflicting \[[@pone.0206147.ref029]\]. The impact of gender as a biologic variable in relation to challenges due to dementia remains elusive \[[@pone.0206147.ref062]\].

The NPI psychosis sub-syndrome in nursing home residents with dementia includes delusions and hallucination \[[@pone.0206147.ref038], [@pone.0206147.ref050]--[@pone.0206147.ref052]\]. The prevalence of clinically significant symptoms of delusion and hallucinations at baseline in the present study was 16 and 6%, respectively. The prevalence and cumulative incidence of clinical significant hallucinations and delusions in our study were comparable to findings in other longitudinal studies of nursing home residents with dementia \[[@pone.0206147.ref019], [@pone.0206147.ref021], [@pone.0206147.ref029], [@pone.0206147.ref036], [@pone.0206147.ref063]\]. The overall mean score of the NPI psychosis sub-syndrome was mostly unchanged during the 30-month follow-up. More severe dementia was associated with a higher NPI psychosis sub-syndrome score, with the association stable over time. In contrast to our study, a study that followed nursing home residents over 53 months reported that the psychosis sub-syndrome score declined somewhat in residents with moderate and severe dementia, but increased in residents with mild dementia \[[@pone.0206147.ref024]\]. The differences in these and our findings may be due to the differences in the length of follow-up, and how the studies handled the inclusion of residents with dementia. Like most other studies of nursing home residents, the 53-month follow-up study included residents with varying lengths of residency prior to study inclusion, while the present study included residents at admission to the nursing home.

We were surprised to find that both the use of antipsychotics and sedatives were associated with higher severity for all NPI sub-syndromes and that the use of antidepressants was associated with a higher severity for the NPI affective sub-syndrome. These findings could be considered counterintuitive. Even if it is known that the use of psychotropic medication may not have the expected effect on NPS \[[@pone.0206147.ref015]\] and could have considerable adverse effects \[[@pone.0206147.ref064]\], we do not know whether the association relates to a lack of benefits or adverse effects from the medication. It could also be that people taking psychotropic medication had had even more severe symptoms prior to starting the medication. Thus, the relationship between the use of psychotropic drugs and severity of NPS needs further attention, and our results should be interpreted with caution.

Strength and limitations {#sec018}
------------------------

The large sample of residents with dementia recruited at nursing home admission is one of the major strengths of our study, because it gave us the opportunity to perform robust analyses and to adjust for many potentially important variables. Secondly, our use of NPI to assess NPS is an important facet of the study, because NPI covers a broad spectrum of symptoms, has been extensively tested \[[@pone.0206147.ref036], [@pone.0206147.ref049], [@pone.0206147.ref065]\], is frequently used \[[@pone.0206147.ref023]\], and is recommended as the core tool in NPS assessments \[[@pone.0206147.ref023]\]. Our use of NPI also allows our study to be compared to other studies, because the tool is frequently used across samples or populations.

The study has some limitations. Firstly, inclusion in the study was not based on a random selection from all nursing homes in Norway's 19 counties, and thus we cannot claim the sample is representative of Norwegian nursing home residents. However, this study included residents from 47 nursing homes located in four counties, and from both small and large nursing homes in urban and rural areas. Secondly, some residents were lost to follow-up due to the nursing home or the resident withdrew from the study (9), or the resident moved to another location, i.e. another nursing home unit (26) or home (21), or for unknown reasons (1). The relatively large number of dropouts is a problem inherent in most longitudinal nursing home studies, and may restrict generalization of the results. However, in the present study, we used statistical methods suitable for unbalanced data sets and included information on all participants at each assessment, including dropouts. Thirdly, we based the assessment of the severity of dementia on the CDR rating of several assessors. The CDR assessment was included in the standardized dementia diagnostic procedure. Even though all health care workers who undertook the data collection participated in a two-day educational course to secure adequate knowledge and high data quality, we cannot rule out the possibility that the large number of assessors could have biased the results. However, the data collection was done under the supervision of 10 research nurses who had attended a five-day training program prior to study start to reduce this risk. Lastly, even though we adjusted for several health and demographic variables in the analysis, pain, which can be a confounder, was not included.

Conclusion {#sec019}
==========

The prevalence and persistence at two consecutive time points of clinically significant NPS was high during the study period. The mean NPI agitation sub-syndrome score increased during the study period, while the mean NPI affective and psychosis sub-syndrome scores remained unchanged. More severe dementia was associated with higher NPI agitation, psychosis and affective sub-syndrome scores. The association remained unchanged over time for agitation and psychosis. For the NPI affective sub-syndrome, the association was stronger at the beginning of the study period, while over time the association related to the severity of dementia declined. These findings may contribute to improve the understanding of the burden and care needs that nursing home residents with dementia pose. Such knowledge is of importance both for health care planners and caregivers in order to increase the quality of care for nursing home residents.
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